Capricor Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $287.8M | $11.3M | $14.7M | $9.6M | $34.9M | $32.7M | $3.9M | $4.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $322.9M | $163.4M | $50.9M | $42.9M | $36.4M | $33.7M | $10.5M | $8.5M |
| Property, Plant & Equipment | $18.3M | $5.6M | $5.6M | $4.6M | $1.8M | $850.8K | $442.8K | $574.2K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $0 | $2.2K | $6.5K | $49.8K |
| Total Assets | $355.9M | $170.5M | $58.7M | $50.1M | $41.3M | $34.6M | $11.1M | $9.2M |
| Liabilities | ||||||||
| Accounts Payable | $1.7M | $3.3M | — | — | — | — | — | — |
| Total Current Liabilities | $35.8M | $21.0M | $31.3M | $23.6M | $4.1M | $3.0M | $898.0K | $1.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $50.2M | $25.0M | $36.1M | $38.3M | $10.0M | $6.4M | $4.3M | $4.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-304.9M | $-199.8M | $-159.4M | $-137.1M | $-108.1M | $-88.0M | $-74.4M | $-66.7M |
| Total Stockholders' Equity | $305.8M | $145.5M | $22.6M | $11.8M | $31.4M | $28.2M | $6.8M | $4.6M |